I've been using a pretty good strategy of selling weekly covered calls on the pops. The ones I sold for today will expire (leaving me with the full premium) and next pop, I'll sell next weeks calls. I don't care if they get called away, I'll buy it back on a dip.
It was a lousy report, but we pretty much expected that. I'm just going to sit on it (still). I'm having a great day thanks to my positions in AMZN, TWTR and VRX though. I think Valeant might just recover over time and do quite well (yeah, I do tend to like underdogs ie: EYES, TWTR, VRX)
It's after market. So, maybe we see Fireworks on Friday!
Second Sight Medical Products, Inc. (EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its fourth quarter and year end 2015 financial results on Thursday, March 3, 2016, after the close of the U.S. financial markets.
it Looks like we are back to the low-volume slide. Oh well, it happened quicker than I expected. Thanks in large part (I'm sure) to that lousy newsletter that I can't remember the name of.
As soon as I saw the headlines of his death, I assumed that his recent resignation was due to health issues. He will certainly be missed by the medical community.
When I read it, I figured it was a hack job done by somebody who was already short EYES (it did disclose they had a short position) and was trying to smash it down to get out with a smaller loss. I'd never heard of this outfit, and I've been around, following this type of stuff for several years.
They got the "may eventually" part right. We sure aren't seeing any price benefit from the good news (yet anyway)